全文获取类型
收费全文 | 21275篇 |
免费 | 1640篇 |
国内免费 | 1516篇 |
出版年
2024年 | 39篇 |
2023年 | 214篇 |
2022年 | 602篇 |
2021年 | 1153篇 |
2020年 | 761篇 |
2019年 | 932篇 |
2018年 | 908篇 |
2017年 | 671篇 |
2016年 | 943篇 |
2015年 | 1293篇 |
2014年 | 1562篇 |
2013年 | 1712篇 |
2012年 | 1884篇 |
2011年 | 1751篇 |
2010年 | 1080篇 |
2009年 | 984篇 |
2008年 | 1132篇 |
2007年 | 999篇 |
2006年 | 856篇 |
2005年 | 736篇 |
2004年 | 566篇 |
2003年 | 545篇 |
2002年 | 444篇 |
2001年 | 324篇 |
2000年 | 326篇 |
1999年 | 327篇 |
1998年 | 189篇 |
1997年 | 171篇 |
1996年 | 181篇 |
1995年 | 176篇 |
1994年 | 159篇 |
1993年 | 117篇 |
1992年 | 158篇 |
1991年 | 113篇 |
1990年 | 110篇 |
1989年 | 77篇 |
1988年 | 54篇 |
1987年 | 46篇 |
1986年 | 35篇 |
1985年 | 35篇 |
1984年 | 17篇 |
1983年 | 15篇 |
1982年 | 16篇 |
1981年 | 7篇 |
1980年 | 4篇 |
1979年 | 2篇 |
1978年 | 1篇 |
1975年 | 2篇 |
1966年 | 1篇 |
1950年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
911.
目的:研究17-丙烯胺-17去甲氧格尔德霉素(17-Allylamino-17-emethoxy-geldanamycin, 17-AAG)对球囊损伤后大鼠颈总动脉内膜增生的影响及可能作用机制。方法:将清洁级雄性SD大鼠36只按照随机数字法分为假手术组(Sham组)12只、球囊损伤组(Balloon injury, BI组)12只及17-AAG治疗组(17-AAG组)12只。采用2F Fogarty球囊建立大鼠颈总动脉球囊损伤组模型,17-AAG治疗组大鼠在建模后腹腔注射17-AGG(20 mg/kg 2d)。各组大鼠于球囊损伤3周后取损伤段颈总动脉,通过HE染色观察血管内膜形态学改变并评估内膜增生情况,免疫组化染色(Immunohistochemical staining,IHS)法检测血管壁增殖细胞核抗原(Proliferating cell nuclear antigen,PCNA)的表达,评估血管平滑肌细胞的增殖情况。流式细胞术检测血管平滑肌细胞的凋亡情况。结果:BI组、17-AAG组大鼠球囊损伤后颈总动脉内膜出现不同程度增生,内膜/中膜面积比(Intima area/Membrane area,I/M)均较Sham组显著升高(P0.05);17-AAG组的I/M较BI组明显下降(P0.05)。BI组、17-AAG组颈总动脉PCNA表达水平较Sham组明显升高(P0.05),较BI组显著降低(P0.05)。BI组、17-AAG组大鼠血管平滑肌细胞凋亡率较Sham组显著升高(P0.05);17-AAG组大鼠血管平滑肌细胞凋亡程度较BI组明显升高(P0.05)。结论:17-AAG对球囊损伤后颈总动脉内膜增生存在抑制作用,其机制可能是通过提高血管平滑肌细胞凋亡率影响其增殖程度。 相似文献
912.
通过对秦岭山区中国大鲵(Andrias davidianus)栖息地生境因子调查、统计,利用R语言分析了各因子与大鲵生境选择的相关性,得出研究结果:秦岭山区影响大鲵生存的主要因子为栖息地类型(相关系数r=0.98),其次是水温(相关系数r=-0.8)、河岸坡度(r=-0.6)和p H (r=-0.6);浊度(相关系数r=0.5)、电导率(r=0.49)、DO(r=0.4)、人为干扰(r=0.35)和海拔(r=0.31)对大鲵分布影响不大。研究结果为探讨中国大鲵对野生环境的适应性选择提供了参考。 相似文献
913.
<正>In an essay written by the evolutionary biologist Theodosius Dobzhansky in 1973, he pointed out that "Nothing in Biology Makes Sense Except in the Light of Evolution." An interesting phenomenon in biology is the presence of variable numbers of chromosomes in different organisms. Besides several species, which possess multiple circular chromosomes or simply linear chromosomes (Baril et al.1989; Suwanto and Kaplan, 1989; Jumas-Bilak et al., 1998),most prokaryotes only possess one circular chromosome. In contrast, the genomes of eukaryotic species are usually packaged into linear chromosomes with numbers varying 相似文献
914.
Guo Hua Cai Chunlin Wang Bo Zhuo Fei Jiang Rendi Wang Ning Li Bei Zhang Wei Zhu Yan Fan Yi Chen Wushen Chen Weihong Yang Xinglou Shi Zhengli 《中国科学:生命科学英文版》2019,62(5):701-704
<正>Dear Editor,Hepatitis C virus (HCV) is a leading global cause of various liver diseases, including chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. The genome of HCV is monopartite, single-stranded, positive RNA, about 10 kb in size.HCV is the prototype species of the Hepacivirus genus,which contains 14 species according to the update from the International Committee on Taxonomy of Viruses (Smith et al., 2016). Prior to 2005, humans were thought to be the only 相似文献
915.
Zhenglong Li Xingming Jiang Lining Huang Jinglin Li Daolin Ji Yi Xu Kaiming Leng Yunfu Cui 《Journal of cellular and molecular medicine》2019,23(12):8258-8268
LncRNAs has been demonstrated to modulate neoplastic development by modulating downstream miRNAs and functional genes. In this study, we aimed to detect the interaction among lncRNA ZFAS1 miR‐296‐5p and USF1. We explored the proliferation, migration and invasion of cholangiocarcinoma. The differentially expressed ZFAS1 was discovered in both tissues and cell lines by qRT‐PCR. The targeting relationship between miR‐296‐5p and ZFAS1 or USF1 was validated by dual‐luciferase assay. The impact of ZFAS1 on CCA cell proliferation was observed by CCK‐8 assay. The protein expression of USF1 was determined by Western blot. The effects of ZFAS1, miR‐296‐5p and USF1 on tumour growth were further confirmed using xenograft model. LncRNA ZFAS1 expression was relatively up‐regulated in tumour tissues and cells while miR‐296‐5p was significantly down‐regulated. Knockdown of ZFAS1 significantly suppressed tumour proliferation, migration, invasion and USF1 expression. Overexpressed miR‐296‐5p suppressed cell proliferation and metastasis. Knockdown of USF1 inhibited cell proliferation and metastasis and xenograft tumour growth. In conclusion, ZFAS1 might promote cholangiocarcinoma proliferation and metastasis by modulating USF1 via miR‐296‐5p. 相似文献
916.
QKI‐6 inhibits bladder cancer malignant behaviours through down‐regulating E2F3 and NF‐κB signalling
917.
Yu‐Han Wang Xiao‐Hui Huang Yan‐Mei Yang Youdi He Xiao‐Hui Dong Hui‐Xin Yang Lei Zhang Yan Wang Jin Zhou Changyong Wang Xiao‐Xia Jiang 《Journal of cellular and molecular medicine》2019,23(5):3737-3746
Adipose‐derived stem cells (ASCs) are highly attractive for cell‐based therapies in tissue repair and regeneration because they have multilineage differentiation capacity and are immunosuppressive. However, the detailed epigenetic mechanisms of their immunoregulatory capacity are not fully defined. In this study, we found that Mysm1 was induced in ASCs treated with inflammatory cytokines. Adipose‐derived stem cells with Mysm1 knockdown exhibited attenuated immunosuppressive capacity, evidenced by less inhibition of T cell proliferation, more pro‐inflammatory factor secretion and less nitric oxide (NO) production in vitro. Mysm1‐deficient ASCs exacerbated inflammatory bowel diseases but inhibited tumour growth in vivo. Mysm1‐deficient ASCs also showed depressed miR‐150 expression. When transduced with Mysm1 overexpression lentivirus, ASCs exhibited enhanced miR‐150 expression. Furthermore, Mysm1‐deficient cells transduced with lentivirus containing miR‐150 mimics produced less pro‐inflammatory factors and more NO. Our study reveals a new role of Mysm1 in regulating the immunomodulatory activities of ASCs by targeting miR‐150. These novel insights into the mechanisms through which ASCs regulate immune reactions may lead to better clinical utility of these cells. 相似文献
918.
Mingyu Zhang Yuan Jiang Xiaofei Guo Bowen Zhang Jiangjiao Wu Jiabin Sun Haihai Liang Hongli Shan Yong Zhang Jiaqi Liu Ying Wang Lu Wang Rong Zhang Baofeng Yang Chaoqian Xu 《Journal of cellular and molecular medicine》2019,23(11):7685-7698
Pathological cardiac hypertrophy (CH) is a key factor leading to heart failure and ultimately sudden death. Long non‐coding RNAs (lncRNAs) are emerging as a new player in gene regulation relevant to a wide spectrum of human disease including cardiac disorders. Here, we characterize the role of a specific lncRNA named cardiac hypertrophy‐associated regulator (CHAR) in CH and delineate the underlying signalling pathway. CHAR was found markedly down‐regulated in both in vivo mouse model of cardiac hypertrophy induced by pressure overload and in vitro cellular model of cardiomyocyte hypertrophy induced by angiotensin II (AngII) insult. CHAR down‐regulation alone was sufficient to induce hypertrophic phenotypes in healthy mice and neonatal rat ventricular cells (NRVCs). Overexpression of CHAR reduced the hypertrophic responses. CHAR was found to act as a competitive endogenous RNA (ceRNA) to down‐regulate miR‐20b that we established as a pro‐hypertrophic miRNA. We experimentally established phosphatase and tensin homolog (PTEN), an anti‐hypertrophic signalling molecule, as a target gene for miR‐20b. We found that miR‐20b induced CH by directly repressing PTEN expression and indirectly increasing AKT activity. Moreover, CHAR overexpression mitigated the repression of PTEN and activation of AKT by miR‐20b, and as such, it abrogated the deleterious effects of miR‐20b on CH. Collectively, this study characterized a new lncRNA CHAR and unravelled a new pro‐hypertrophic signalling pathway: lncRNA‐CHAR/miR‐20b/PTEN/AKT. The findings therefore should improve our understanding of the cellular functionality and pathophysiological role of lncRNAs in the heart. 相似文献
919.
920.
Xinshu Xie Saisai Xie Changying Xie Yuanying Fang Zhifeng Li Rikang Wang Wei Jiang 《Journal of cellular and molecular medicine》2019,23(11):7545-7553
Uveal melanoma (UM) has a high mortality rate due to liver metastasis. The insulin‐like growth factor‐1 receptor (IGF‐1R) is highly expressed in UM and has been shown to be associated with hepatic metastases. Targeting IGF signalling may be considered as a promising approach to inhibit the process of metastatic UM cells. Pristimerin (PRI) has been demonstrated to inhibit the growth of several cancer cells, but its role and underlying mechanisms in the IGF‐1‐induced UM cell proliferation are largely unknown. The present study examined the anti‐proliferative effect of PRI on UM cells and its possible role in IGF‐1R signalling transduction. MTT and clonogenic assays were used to determine the role of PRI in the proliferation of UM cells. Flow cytometry was performed to detect the effect of PRI on the cell cycle distribution of UM cells. Western blotting was carried out to assess the effects of PRI and IGF‐1 on the IGF‐1R phosphorylation and its downstream targets. The results indicated that IGF‐1 promoted the UM cell proliferation and improved the level of IGF‐1R phosphorylation, whereas PRI attenuated the effect of IGF‐1. Interestingly, PRI could not only induce the G1 phase accumulation and reduce the G2 phase induced by IGF‐1, but also could stimulate the expression of p21 and inhibit the expression of cyclin D1. Besides, PRI could attenuate the phosphorylations of Akt, mTOR and ERK1/2 induced by IGF‐1. Furthermore, the molecular docking study also demonstrated that PRI had potential inhibitory effects on IGF‐1R. Taken together, these results indicated that PRI could inhibit the proliferation of UM cells through down‐regulation of phosphorylated IGF‐1R and its downstream signalling. 相似文献